International Journal of Rheumatic Diseases《国际风湿病杂志》(可官网投稿)

International Journal of Rheumatic Diseases《国际风湿病杂志》(月刊). The International Journal of Rheumatic Diseases publishes original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders.

杂志简称:int j rheum dis
中文译名:《国际风湿病杂志》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:3.50%
投稿方向:医学、rheumatology 风湿病学

International Journal of Rheumatic Diseases《国际风湿病杂志》

SCI/E期刊基本信息

出版周期:月刊 地区:美国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN1756-1841;EISSN1756-185X
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:WILEY-BLACKWELL PUBLISHING,INC,COMMERCE PLACE,350 MAIN ST,MALDEN,USA,MA,02148
杂志邮箱:
投稿网址:http://mc.manuscriptcentral.com/aplar
杂志官方网址:https://onlinelibrary.wiley.com/journal/1756185x
出版商网址:http://www.wiley.com/WileyCDA/

杂志投稿要求

投稿须知【杂志社官方网站信息】

International Journal of Rheumatic Diseases

Author Guidelines

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at mc.manuscriptcentral.com/aplar

If you are currently a reviewer for our journal please email ijrd.eo@wiley.com for your Login ID and Password. If you are new to the journal please create an author account for yourself by clicking the link on the top right hand corner of the webpage. After logging in you will be able to submit your paper by following the steps. When uploading your manuscript please note that all figures should be uploaded in separate eps or tiff files (See Figures section below). Please email ijrd.eo@wiley.com if you have any difficulties.

Click here for more details on how to use ScholarOne.

Queries regarding submissions should be sent to the IJRD Editorial Office at: ijrd.eo@wiley.com

2. AIMS AND SCOPE

International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Editorial

Editorials are commissioned by the Editor-in-Chief, though unsolicited editorials may be considered.

Invited Reviews

Reviews are comprehensive analyses of specific topics either basic or clinical. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in such cases authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance. They should contain a maximum of 4000 words (excluding Abstract, Tables, and References).

Original articles

Original Articles should reflect original work that embodies scientific excellence in rheumatology and advances in clinical research. They should contain a maximum of 4000 words (excluding Abstract, Tables, and References) and must contain a structured Abstract of 250 words or less together with a list of key words and up to 6 tables or figures and a maximum of 50 references. Divide the Abstract with the headings: Aim, Method, Results, Conclusion.

Novel Hypothesis

Novel Hypothesis offers the researchers an opportunity to raise a clinical or experimental hypothesis,which is based on Biological basis, but yet to be proven. The text is limited to a maximum of 1,000 words including abstract but excluding references, tables and figures. No abstract is required.

APLAR Grand Round Case

APLAR Grand Round Case is an exceptional case with novel message and in depth work up and educative discussion, the text is limited to 1500 words, the case should preferably be from APLAR nations. Before submitting an APLAR Grand Round Case for review, approval should be sought from the Editorial Office (ijrd.eo@wiley.com). Submissions without prior approval will not be considered for review.

Postgraduate Quiz

Postgraduate Quiz can include a number of images of rare, classical or interesting case, each image should be accompanied by a brief summary of the case (if appropriate) and question(s) that are designed to test the participant's knowledge. The answer(s) should follow separately and should include a brief description of the diagnostic features of the image and the key learning points. The text is limited to 1000 words. Prior to submitting a Postgraduate Quiz for review, approval should be sought from the Editorial Office (ijrd.eo@wiley.com). Submissions without prior approval will not be considered for review.

Expert Comments on Recent Publications

Expert Comments on Recent Publications are solicited by the Editor-in-Chief. Top expert(s) will be invited to summarise top 10 publications within the recent past 2 months with relevant learning points. The text is limited to 1500 words.

Correspondence

Correspondence discuss a recent article published in the IJRD. Correspondence being considered for publication will be sent to the authors of the IJRD article, who will be given the opportunity to reply. Interesting case reports may be published under this category. They should be no more than 1000 words with a maximum of 10 references and up to 2 figures or tables. No Abstract or key words are required.

Please note that the IJRD is not currently accepting correspondence, case reports, case letters except where directly addressing a previously-published IJRD article

Milestones in Science, Art and Commerce of Rheumatology

This column reviews landmark developments of rheumatology, including write ups about great scientists in rheumatology or exemplary patients. The text is limited to 1500 words.

4. PREPARING YOUR SUBMISSION

Cover Letters

• A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.

• The cover letter must include: (i) an acknowledgment that all authors have contributed significantly and are in agreement with the content of the manuscript, (ii) a statement confirming that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html, (iii) a declaration of any financial support or relationships that may pose conflict of interest.

Style

• Manuscripts should follow the style of the Vancouver agreement detailed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as presented in JAMA 1997; 277: 927–34.

• The journal uses US spelling and authors should therefore follow the latest edition of Merriam–Webster’s Collegiate Dictionary.

• Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at www.bipm.fr for more information about SI units.

• Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation.

• Drugs should be referred to by their generic names, rather than brand names.

• The main text file should be prepared using Microsoft Word, doubled-spaced. The top, bottom and side margins should be 30 mm. New paragraphs should be indented.

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file (title page should be included) and figures. The main text file should contain:

i. A short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice tips for Search Engine Optimisation);

ii. A short running title of less than 40 characters;

iii. The full names of the authors;

iv. The author's institutional affiliations at which the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;

v. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified;

vi. Acknowledgements;

vii. Abstract and keywords;

viii. Main text;

ix. References;

x. Tables (each table complete with title and footnotes);

xi. Figure legends;

xii. Appendices (if relevant).

Figures and Supporting Information should be supplied as separate files.

Authorship

Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract

Please refer to the section on Manuscript Categories and Requirements above for information regarding which article types require abstracts.

Keywords

Please provide 5-7 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.

Main text

Please refer to the section on Manuscript Categories and Requirements above for information regarding requirements for different article types.

References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should be superscript numbers. Journal titles are abbreviated; abbreviations may be found in the following: MEDLINE, Index Medicus, or CalTech Library

Submissions are not required to reflect the precise reference formatting of the journal (use of italics, bold etc.), however it is important that all key elements of each reference are included. Please see below for examples of reference content requirements. For more information, please see the Vancouver Reference Style Guide.

Sample references follow:

Journal article

1. Needleman P, Isakson PC (1997) The discovery and function of COX-2. J Rheumatol 24,6–7.

Book

2. Munthe E (ed.) The Care of Rheumatic Children. European League Against Rheumatism, Basel, Switzerland.

Chapter in a book

3. Croft P (1993) Soft tissue rheumatism. In: AJ Silman, MC Hochberg (eds) Epidemiology of the Rheumatic Diseases, pp. 375–421. Oxford University Press, Oxford.

Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Supporting Information

Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online, and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.

Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

Wiley Author Resources

Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation and Formatting Support: Wiley Editing Services can greatly improve the chances of your manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting and figure preparation, Wiley Editing Services ensures that your manuscript is ready for submission.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/40543

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 上午11:41
下一篇 2024年11月9日 上午11:41

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息